For women in Indore, Bhopal, Ujjain, Jabalpur, and the broader central-India catchment with a Stage III ovarian cancer diagnosis, one decision has historically been pivotal: where to receive cytoreductive surgery with HIPEC. The procedure has been available in Mumbai and a small number of metros for over a decade, but it has not been within practical reach for most central-India families because of the combined travel, lodging, and total cost burden.
That picture has changed materially. Ahmedabad, a 6–8 hour road journey from Indore, similar from Bhopal, now offers HIPEC at sub-speciality centres with infrastructure equivalent to Mumbai’s tertiary hospitals. For many central-India families, this changes the practical answer to “where should we go for this surgery.”
Why HIPEC matters for advanced ovarian cancer
HIPEC, hyperthermic intraperitoneal chemotherapy, is the addition of heated chemotherapy fluid to the abdominal cavity at the conclusion of cytoreductive surgery for advanced ovarian cancer. The chemotherapy circulates at 41–43 °C for 60–90 minutes, killing microscopic residual cancer cells in a way that systemic chemotherapy alone does not.
For appropriately selected patients, Stage III epithelial ovarian, fallopian tube, or primary peritoneal cancer undergoing interval cytoreductive surgery after neoadjuvant chemotherapy, adding HIPEC to complete cytoreduction has been shown to produce durable, measurable improvements in both recurrence-free and overall survival. The evidence base is anchored by the OVHIPEC-1 trial (NEJM 2018) and supported by subsequent series.
The qualifier is “appropriately selected.” HIPEC is not for every ovarian cancer patient. The criteria are specific, and patient selection by a multidisciplinary tumour board matters as much as the procedure itself.
What Ahmedabad now offers that Mumbai used to monopolise
For central-India patients, the relevant capabilities are:
- Sub-speciality gynaec oncosurgeons with fellowship training in gynaecological oncology specifically.
- Cytoreductive surgery infrastructure, operating theatres, ICU, ward capacity for complex 6–12 hour operations with 10–14 day post-operative stays.
- HIPEC capability, the equipment, training, and protocol-level experience to safely perform the procedure.
- ERAS protocols, enhanced recovery after surgery, which substantially improves the post-operative experience without changing the procedure itself.
- Multidisciplinary tumour boards for case review before surgery.
- PIPAC for recurrent cases requiring this newer modality.
All six are now established in Ahmedabad’s main tertiary centres. The functional equivalence with Mumbai for these specific procedures is genuine.
The cost and logistics comparison
For a representative central-India family weighing the choice between Ahmedabad and Mumbai for the same procedure:
Travel from Indore: – To Ahmedabad: 400 km, 6–7 hour drive, or 1-hour flight (multiple daily options) – To Mumbai: 590 km, 9-10 hour drive, or 1-hour flight (more flight options, higher prices)
Travel from Bhopal: – To Ahmedabad: 575 km, 8–9 hour drive, or 1-hour flight – To Mumbai: 770 km, 12-hour drive, or 1.5-hour flight
Surgical cost (cytoreductive surgery with HIPEC, mid-range hospital package): – Ahmedabad: ₹6–10 lakh – Mumbai premium tertiary: ₹10–18 lakh
Accommodation cost (family stay during 10–14 day post-operative period): – Ahmedabad (Sindhubhavan area): ₹1,500–4,500 per night – Mumbai (Bandra-Andheri area): ₹4,000–10,000 per night
For most central-India families, the total all-in cost of treatment in Ahmedabad is 30–50% lower than Mumbai for equivalent clinical care.
What the clinical equivalence actually means
The historical assumption that Mumbai provides materially better surgical outcomes than Ahmedabad for HIPEC is not strongly supported by current data. Surgical outcomes for cytoreductive surgery depend most on:
- Sub-speciality training of the operating surgeon
- Annual case volume of the operating team
- ICU and rehabilitation infrastructure
- ERAS protocol adherence
All four are now well-established in Ahmedabad’s main centres performing this procedure. For most cases, the marginal clinical advantage of Mumbai over Ahmedabad, if any, does not justify the additional cost and family disruption.
The clear exceptions where Mumbai or another super-tertiary centre is the right answer: – Very rare or histologically unusual cases needing super-specialised pathology review – Clinical trial eligibility specific to a Mumbai centre – Patient or family preference based on a specific surgeon they know
What central-India patients actually consult for
Common reasons women from Indore, Bhopal, Ujjain, Jabalpur, and surrounding areas seek HIPEC for Indore Bhopal patients consultation in Ahmedabad:
- A newly diagnosed Stage III ovarian cancer, needing HIPEC eligibility review
- A current treatment plan in progress at a local hospital that does not include HIPEC, with a question of whether it should
- Recurrent ovarian cancer, with a question of secondary cytoreduction and PIPAC eligibility
- Complex pre-existing diagnosis being revisited
For most of these scenarios, an initial WhatsApp-based report review is the right first step before committing to travel.
The actual workflow for central-India patients
For a family in Indore or Bhopal facing this decision, the practical pathway:
Week 1: Send all reports, pathology, imaging (including imaging discs in digital form), tumour markers, treatment summaries, via WhatsApp to +91 76988 00333. Initial specialist review and recommendation typically within 24–48 hours.
Week 2: If in-person consultation is indicated, schedule a 1–2 day trip to Ahmedabad. Bundle blood work, additional investigations, and consultation in the same visit. Most patients receive a clear recommended pathway by the end of this visit.
Week 3–5: Pre-operative optimisation (nutritional support, medical optimisation) typically managed locally with the local team in coordination with the Ahmedabad specialist team.
Surgical admission: Plan for 10–14 days of hospital stay plus 2–3 additional days for safe travel home. Family accommodation near Sindhubhavan is well-developed.
Post-operative follow-up: First visit at 2 weeks (in Ahmedabad), then alternating between local team (for chemotherapy administration and routine bloods) and Ahmedabad team (for major treatment decisions) is the typical pattern.
The bottom line
For central-India families navigating advanced ovarian cancer with possible HIPEC indication, the historical “Mumbai or local-only” choice has been replaced by a meaningful third option in Ahmedabad. The clinical capability is now equivalent for these specific procedures, the cost is materially lower, and the travel logistics are simpler.
The right first step is a WhatsApp-based specialist review of your reports. Most cases can be triaged remotely before any travel decision is made.
About the author
This article was authored by Dr. Nishtha Tripathi Patel (MBBS, DGO, DNB, Fellowship in Gynaecological Oncology, ESGO-certified), an ESGO-certified gynaecological oncosurgeon in Ahmedabad treating patients from across central India for advanced gynaecological cancer surgery, HIPEC, and PIPAC. Reach her practice at +91 76988 00333.
